RÉSUMÉ
Omega-3 fatty acids have multiple effects in peripheral tissues and pancreatic beta cell function. Dietary depletion of omega-3 fatty acids is associated with pancreatic islet dysfunction and insulin resistance in rats. Herein, the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on pancreatic beta cell redox state and function were investigated. INS-1E insulin-secreting cells were incubated with EPA and DHA in combination with palmitic acid, and productions of reactive oxygen species (ROS), nitric oxide (NO) and insulin were measured. The involvement of the NADPH oxidase complex in ROS production and expression of the antioxidant enzymes was also investigated. After incubation for 1 or 48 h, productions of superoxide (by hydroethidine method), nitric oxide (by 4,5-diaminofluorescein diacetate-DAF-2DA assay), insulin (by radioimmunoassay), and expressions (by western blot analysis) of glutathione peroxidase (GPx-1) and gp91PHOX were measured. EPA and DHA reduced superoxide production after 1-h incubation. After 48 h, palmitic acid reduced superoxide production that was normalized by EPA treatment. Palmitic acid increased NO production that was reverted by EPA and DHA. Palmitic acid increased insulin secretion after 48 h, whereas both omega-3 fatty acids increased intracellular insulin content. EPA and DHA enhanced GPx-1 expression as well as gp91PHOX glycosylated form. In conclusion, EPA and DHA increased intracellular insulin content and antioxidant enzymatic defense capacity and decreased pro-oxidant generating activities that are associated with maintenance of pancreatic beta cell redox state in response to palmitic acid.
Sujet(s)
Acide docosahexaénoïque/pharmacologie , Acide eicosapentanoïque/pharmacologie , Cellules à insuline/effets des médicaments et des substances chimiques , Insuline/biosynthèse , Monoxyde d'azote/métabolisme , Superoxydes/métabolisme , Animaux , Lignée cellulaire , Régulation de l'expression des gènes , Glutathione peroxidase/génétique , Glutathione peroxidase/métabolisme , Insuline/agonistes , Cellules à insuline/cytologie , Cellules à insuline/métabolisme , Glycoprotéines membranaires/génétique , Glycoprotéines membranaires/métabolisme , NADPH Oxidase 2 , NADPH oxidase/génétique , NADPH oxidase/métabolisme , Monoxyde d'azote/antagonistes et inhibiteurs , Acide palmitique/antagonistes et inhibiteurs , Acide palmitique/pharmacologie , Rats , Transduction du signal , Superoxydes/antagonistes et inhibiteurs , Glutathione Peroxydase GPX1RÉSUMÉ
[11C]PIB is the most used amyloid plaques-specific positron-emitting radiotracers. The radiosynthesis of this compound, carried out by methylation of its precursor with [11C]methyl triflate in 2-butanone, has been improved optimizing the initial concentration and the purification method. Two HPLC methods were compared: good radiochemical yields, specific activities, and chemical purity above 98% were achieved by using as eluant acetonitrile/citrate and formulation in 10% ethanol.
Sujet(s)
Maladie d'Alzheimer/imagerie diagnostique , Peptides bêta-amyloïdes/métabolisme , Benzothiazoles/synthèse chimique , Radio-isotopes du carbone , Tomographie par émission de positons/méthodes , Radiopharmaceutiques/synthèse chimique , Maladie d'Alzheimer/diagnostic , Maladie d'Alzheimer/métabolisme , Dérivés de l'aniline , Benzothiazoles/isolement et purification , Benzothiazoles/normes , Radio-isotopes du carbone/isolement et purification , Radio-isotopes du carbone/normes , Humains , Contrôle de qualité , Radiopharmaceutiques/isolement et purification , Radiopharmaceutiques/normes , ThiazolesRÉSUMÉ
Long-chain fatty acids are capable of inducing alterations in the homoeostasis of glucose-stimulated insulin secretion (GSIS), but the effect of medium-chain fatty acids (MCFA) is poorly elucidated. In the present study, we fed a normoenergetic MCFA diet to male rats from the age of 1 month to the age of 4 months in order to analyse the effect of MCFA on body growth, insulin sensitivity and GSIS. The 45% MCFA substitution of whole fatty acids in the normoenergetic diet impaired whole body growth and resulted in increased body adiposity and hyperinsulinaemia, and reduced insulin-mediated glucose uptake in skeletal muscle. In addition, the isolated pancreatic islets from the MCFA-fed rats showed impaired GSIS and reduced protein kinase Ba (AKT1) protein expression and extracellular signal-related kinase isoforms 1 and 2 (ERK(1/2)) phosphorylation, which were accompanied by increased cellular death. Furthermore, there was a mildly increased cholinergic sensitivity to GSIS. We discuss these findings in further detail, and advocate that they might have a role in the mechanistic pathway leading to the compensatory hyperinsulinaemic status found in this animal model.
Sujet(s)
Matières grasses alimentaires/métabolisme , Acides gras/métabolisme , Insulinorésistance/physiologie , Ilots pancréatiques/métabolisme , Récepteur à l'insuline/métabolisme , Triglycéride/sang , Animaux , Modèles animaux de maladie humaine , Acides gras/composition chimique , Facteur de croissance IGF-I/métabolisme , Mâle , Muscles squelettiques/métabolisme , Phosphorylation/physiologie , Protéine kinase C/métabolisme , Protéines proto-oncogènes c-akt/métabolisme , Rats , Rat Wistar , Triglycéride/composition chimiqueRÉSUMÉ
Flavonoids, in general, have potent antioxidant activity and they can be used in treating chronic diseases involving oxidative stress, such as diabetes mellitus. The purpose of this study was to evaluate the cytotoxicity and cytoprotective effects of citrus flavonoids on the functionality of BRIN-BD11 cells. The assessment of cytotoxic and cytoprotective flavonoid tested was performed using the MTT reduction assay. The flavonoids did not show cytotoxic effects in any of the tested concentrations (5-20 µM) and also negative insulinotropic effects were not observed. To cytoprotective assay, the IC50 of H2O2 in treatment of 2 h (acute oxidative stress) was measured (350 µM). Moreover, under acute oxidative stress, the isolated flavonoids (10 µM) had no cytoprotective effects. Besides an antioxidant role of the flavonoids was only observed when using in association. Thus future experiments are needed, varying the experimental condition, to better evaluate the possible mechanisms of action of these flavonoids.
Sujet(s)
Citrus/composition chimique , Flavonoïdes/pharmacologie , Cellules à insuline/effets des médicaments et des substances chimiques , Cellules à insuline/métabolisme , Lignée cellulaire tumorale , Flavonoïdes/composition chimique , Humains , Peroxyde d'hydrogène/pharmacologie , Stress oxydatif/effets des médicaments et des substances chimiquesRÉSUMÉ
Growing evidence indicates that the regulation of intracellular reactive oxygen species (ROS) and reactive nitrogen species (RNS) levels is essential for maintaining normal ß-cell glucose responsiveness. While long-term exposure to high glucose induces oxidative stress in ß cells, conflicting results have been published regarding the impact of ROS on acute glucose exposure and their role in glucose stimulated insulin secretion (GSIS). Although ß cells are considered to be particularly vulnerable to oxidative damage, as they express relatively low levels of some peroxide-metabolizing enzymes such as catalase and glutathione (GSH) peroxidase, other less known GSH-based antioxidant systems are expressed in ß cells at higher levels. Herein, we discuss the key mechanisms of ROS/RNS production and their physiological function in pancreatic ß cells. We also hypothesize that specific interactions between RNS and ROS may be the cause of the vulnerability of pancreatic ß cells to oxidative damage. In addition, using a hypothetical metabolic model based on the data available in the literature, we emphasize the importance of amino acid availability for GSH synthesis and for the maintenance of ß-cell function and viability during periods of metabolic disturbance before the clinical onset of diabetes.
Sujet(s)
Acides aminés/métabolisme , Antioxydants/métabolisme , Cellules à insuline/métabolisme , Espèces réactives de l'azote/métabolisme , Espèces réactives de l'oxygène/métabolisme , Glucose/métabolisme , Glucose/pharmacologie , Glutathion/métabolisme , Humains , Insuline/métabolisme , Sécrétion d'insuline , Cellules à insuline/effets des médicaments et des substances chimiques , Modèles biologiquesRÉSUMÉ
Angiotensin II (AII), the active component of the renin angiotensin system (RAS), plays a vital role in the regulation of physiological processes of the cardiovascular system, but also has autocrine and paracrine actions in various tissues and organs. Many studies have shown the existence of RAS in the pancreas of humans and rodents. The aim of this study was to evaluate potential signaling pathways mediated by AII in isolated pancreatic islets of rats. Phosphorylation of MAPKs (ERK1/2, JNK and p38MAPK), and the interaction between proteins JAK/STAT were evaluated. AII increased JAK2/STAT1 (42%) and JAK2/STAT3 (100%) interaction without altering the total content of JAK2. Analyzing the activation of MAPKs (ERK1/2, JNK and p38MAPK) in isolated pancreatic islets from rats we observed that AII rapidly (3 min) promoted a significant increase in the phosphorylation degree of these proteins after incubation with the hormone. Curiously JNK protein phosphorylation was inhibited by DPI, suggesting the involvement of NAD(P)H oxidase in the activation of protein.
Sujet(s)
Angiotensine-II/pharmacologie , Ilots pancréatiques/effets des médicaments et des substances chimiques , Ilots pancréatiques/métabolisme , Kinase Janus-2/métabolisme , NADPH oxidase/métabolisme , Vasoconstricteurs/pharmacologie , Animaux , Apoptose/effets des médicaments et des substances chimiques , Technique de Western , Femelle , Ilots pancréatiques/cytologie , Mitogen-Activated Protein Kinase 1/métabolisme , Mitogen-Activated Protein Kinase 3/métabolisme , Phosphorylation/effets des médicaments et des substances chimiques , Rats , Espèces réactives de l'oxygène/métabolisme , Facteur de transcription STAT-3/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , p38 Mitogen-Activated Protein Kinases/métabolismeRÉSUMÉ
It is now widely accepted that reactive oxygen species (ROS) contribute to cell and tissue dysfunction and damage in diabetes. The source of ROS in the insulin secreting pancreatic beta cells has traditionally been considered to be the mitochondrial electron transport chain. While this source is undoubtedly important, we fully describe in this article recent information and evidence of NADPH oxidase-dependent generation of ROS in pancreatic beta cells and identify the various isoforms that contribute to O(2)(*-) and H(2)O(2) production in various conditions. While glucose-stimulated ROS generation may be important for acute regulation of insulin secretion, at higher levels ROS may disrupt mitochondrial energy metabolism. However, ROS may alter other cellular processes such as signal transduction, ion fluxes and/or cell proliferation/death. The various beta cell isoforms of NADPH oxidase (described in this review) may, via differences in the kinetics and species of ROS generated, positively and negatively regulate insulin secretion and cell survival.
Sujet(s)
Cellules à insuline/enzymologie , NADPH oxidase/métabolisme , Membrane cellulaire/enzymologie , Diabète/physiopathologie , Glucose/métabolisme , Homéostasie , Humains , Insuline/métabolisme , Sécrétion d'insuline , Cellules à insuline/physiologie , Isoenzymes/métabolisme , Oxydoréduction , Phosphorylation , Espèces réactives de l'oxygène/métabolismeRÉSUMÉ
We previously described the presence of nicotinamide adenine dinucleotide phosphate reduced form [NAD(P)H]oxidase components in pancreatic beta-cells and its activation by glucose, palmitic acid, and proinflammatory cytokines. In the present study, the importance of the NAD(P)H oxidase complex for pancreatic beta-cell function was examined. Rat pancreatic islets were incubated in the presence of glucose plus diphenyleneiodonium, a NAD(P)H oxidase inhibitor, for 1 h or with the antisense oligonucleotide for p47(PHOX) during 24 h. Reactive oxygen species (ROS) production was determined by a fluorescence assay using 2,7-dichlorodihydrofluorescein diacetate. Insulin secretion, intracellular calcium responses, [U-(14)C]glucose oxidation, and expression of glucose transporter-2, glucokinase and insulin genes were examined. Antisense oligonucleotide reduced p47(PHOX) expression [an important NAD(P)H oxidase cytosolic subunit] and similarly to diphenyleneiodonium also blunted the enzyme activity as indicated by reduction of ROS production. Suppression of NAD(P)H oxidase activity had an inhibitory effect on intracellular calcium responses to glucose and glucose-stimulated insulin secretion by isolated islets. NAD(P)H oxidase inhibition also reduced glucose oxidation and gene expression of glucose transporter-2 and glucokinase. These findings indicate that NAD(P)H oxidase activation plays an important role for ROS production by pancreatic beta-cells during glucose-stimulated insulin secretion. The importance of this enzyme complex for the beta-cell metabolism and the machinery involved in insulin secretion were also shown.
Sujet(s)
Glucose/pharmacologie , Cellules à insuline/effets des médicaments et des substances chimiques , Insuline/métabolisme , NADPH oxidase/physiologie , Animaux , Signalisation calcique/effets des médicaments et des substances chimiques , Cellules cultivées , Relation dose-effet des médicaments , Antienzymes/pharmacologie , Femelle , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Glucose/métabolisme , Peroxyde d'hydrogène/métabolisme , Sécrétion d'insuline , Cellules à insuline/métabolisme , NADPH oxidase/antagonistes et inhibiteurs , NADPH oxidase/génétique , Composés onium/pharmacologie , Oxydoréduction/effets des médicaments et des substances chimiques , Petit ARN interférent/pharmacologie , Rats , Rat Wistar , Espèces réactives de l'oxygène/métabolismeRÉSUMÉ
Angiotensin II (Ang II) controls blood pressure, electrolyte balance, cell growth and vascular remodeling. Ang II activates NAD(P)H oxidase in several tissues with important function in the control of insulin secretion. Considering the concomitant occurrence of hypertension, insulin resistance and pancreatic B cell secretion impairment in the development of type II diabetes the aim of the present study was to evaluate the effect of ANG II on NAD(P)H oxidase activation in isolated pancreatic islets. We found that ANGII-induced superoxide generation via NAD(P)H oxidase activation and increased protein and mRNA levels of NAD(P)H oxidase subunits (p47(PHOX) and gp91(PHOX)).
Sujet(s)
Angiotensine-II/pharmacologie , Ilots pancréatiques/effets des médicaments et des substances chimiques , NADPH oxidase/métabolisme , Superoxydes/métabolisme , Angiotensine-II/métabolisme , Animaux , Activation enzymatique , Femelle , Ilots pancréatiques/cytologie , Ilots pancréatiques/métabolisme , Rats , Récepteur de type 1 à l'angiotensine-II/métabolismeRÉSUMÉ
Melatonin diminishes insulin release through the activation of MT1 receptors and a reduction in cAMP production in isolated pancreatic islets of neonate and adult rats and in INS-1 cells (an insulin-secreting cell line). The pancreas of pinealectomized rats exhibits degenerative pathological changes with low islet density, indicating that melatonin plays a role to ensure the functioning of pancreatic beta cells. By using immunoprecipitation and immunoblotting analysis we demonstrated, in isolated rat pancreatic islets, that melatonin induces insulin growth factor receptor (IGF-R) and insulin receptor (IR) tyrosine phosphorylation and mediates the activities of the PI3K/AKT and MEK/ERKs pathways, which are involved in cell survival and growth, respectively. Thus, the effects of melatonin on pancreatic islets do not involve a reduction in cAMP levels only. This indoleamine may regulate growth and differentiation of pancreatic islets by activating IGF-I and insulin receptor signaling pathways.
Sujet(s)
Facteur de croissance IGF-I/métabolisme , Ilots pancréatiques/métabolisme , Mélatonine/métabolisme , Récepteur à l'insuline/métabolisme , Récepteur de la mélatonine de type MT1/métabolisme , Protéines adaptatrices de la transduction du signal/métabolisme , Animaux , Femelle , Techniques in vitro , Insuline/métabolisme , Substrats du récepteur à l'insuline , Sécrétion d'insuline , Système de signalisation des MAP kinases/physiologie , Phosphorylation , Protein Tyrosine Phosphatase, Non-Receptor Type 1/métabolisme , Protéines proto-oncogènes c-akt/métabolisme , Rats , Récepteur IGF de type 1/métabolisme , Facteur de transcription STAT-3/métabolismeRÉSUMÉ
PURPOSE: Huntington's disease (HD) is a progressive neurodegenerative disorder, which is characterised by prominent neuronal cell loss in the basal ganglia with motor and cognitive disturbances. One of the most well-studied pharmacological models of HD is produced by local injection in the rat brain striatum of the excitotoxin quinolinic acid (QA), which produces many of the distinctive features of this human neurodegenerative disorder. Here, we report a detailed analysis, obtained both in vivo and in vitro of this pharmacological model of HD. MATERIALS AND METHODS: By combining emission tomography (PET) with autoradiographic and immunocytochemical confocal laser techniques, we quantified in the QA-injected striatum the temporal behavior (from 1 to 60 days from the excitotoxic insult) of neuronal cell density and receptor availability (adenosine A(2A) and dopamine D(2) receptors) together with the degree of microglia activation. RESULTS: Both approaches showed a loss of adenosine A(2A) and dopamine D(2) receptors paralleled by an increase of microglial activation. CONCLUSION: This combined longitudinal analysis of the disease progression, which suggested an impairment of neurotransmission, neuronal integrity and a reversible activation of brain inflammatory processes, might represent a more quantitative approach to compare the differential effects of treatments in slowing down or reversing HD in rodent models with potential applications to human patients.
Sujet(s)
Corps strié/physiologie , Microglie/physiologie , Dégénérescence nerveuse/induit chimiquement , Raclopride/pharmacologie , Animaux , Radio-isotopes du carbone , Corps strié/effets des médicaments et des substances chimiques , Isoquinoléines/pharmacocinétique , Cinétique , Microglie/effets des médicaments et des substances chimiques , Acide quinolinique/toxicité , Raclopride/pharmacocinétique , Technique de dilution radioisotopique , Rats , Rat Wistar , Récepteur D2 de la dopamine/effets des médicaments et des substances chimiques , Récepteur D2 de la dopamine/physiologie , Récepteurs purinergiques P1/effets des médicaments et des substances chimiques , Récepteurs purinergiques P1/physiologie , Valeurs de référence , Techniques stéréotaxiquesRÉSUMÉ
It is now widely accepted, given the current weight of experimental evidence, that reactive oxygen species (ROS) contribute to cell and tissue dysfunction and damage caused by glucolipotoxicity in diabetes. The source of ROS in the insulin secreting pancreatic beta-cells and in the cells which are targets for insulin action has been considered to be the mitochondrial electron transport chain. While this source is undoubtably important, we provide additional information and evidence for NADPH oxidase-dependent generation of ROS both in pancreatic beta-cells and in insulin sensitive cells. While mitochondrial ROS generation may be important for regulation of mitochondrial uncoupling protein (UCP) activity and thus disruption of cellular energy metabolism, the NADPH oxidase associated ROS may alter parameters of signal transduction, insulin secretion, insulin action and cell proliferation or cell death. Thus NADPH oxidase may be a useful target for intervention strategies based on reversing the negative impact of glucolipotoxicity in diabetes.
Sujet(s)
Diabète de type 2/physiopathologie , Mitochondries/physiologie , Espèces réactives de l'oxygène/métabolisme , Animaux , Apoptose/physiologie , Diabète de type 2/anatomopathologie , Humains , Insulinorésistance/physiologie , Cellules à insuline/anatomopathologie , Cellules à insuline/physiologie , NADPH oxidase/physiologie , Stress oxydatif/physiologieRÉSUMÉ
AIMS/HYPOTHESIS: Acute or chronic exposure of beta cells to glucose, palmitic acid or pro-inflammatory cytokines will result in increased production of the p47(phox) component of the NADPH oxidase and subsequent production of reactive oxygen species (ROS). METHODS: Rat pancreatic islets or clonal rat BRIN BD11 beta cells were incubated in the presence of glucose, palmitic acid or pro-inflammatory cytokines for periods between 1 and 24 h. p47(phox) production was determined by western blotting. ROS production was determined by spectrophotometric nitroblue tetrazolium or fluorescence-based hydroethidine assays. RESULTS: Incubation for 24 h in 0.1 mmol/l palmitic acid or a pro-inflammatory cytokine cocktail increased p47(phox) protein production by 1.5-fold or by 1.75-fold, respectively, in the BRIN BD11 beta cell line. In the presence of 16.7 mmol/l glucose protein production of p47(phox) was increased by 1.7-fold in isolated rat islets after 1 h, while in the presence of 0.1 mmol/l palmitic acid or 5 ng/ml IL-1beta it was increased by 1.4-fold or 1.8-fold, respectively. However, palmitic acid or IL-1beta-dependent production was reduced after 24 h. Islet ROS production was significantly increased after incubation in elevated glucose for 1 h and was completely abolished by addition of diphenylene iodonium, an inhibitor of NADPH oxidase or by the oligonucleotide anti-p47(phox). Addition of 0.1 mmol/l palmitic acid or 5 ng/ml IL-1beta plus 5.6 mmol/l glucose also resulted in a significant increase in islet ROS production after 1 h, which was partially attenuated by diphenylene iodonium or the protein kinase C inhibitor GF109203X. However, ROS production was reduced after 24 h incubation. CONCLUSIONS/INTERPRETATION: NADPH oxidase may play a key role in normal beta cell physiology, but under specific conditions may also contribute to beta cell demise.
Sujet(s)
Cytokines/pharmacologie , Glucose/pharmacologie , Cellules à insuline/enzymologie , Ilots pancréatiques/enzymologie , NADPH oxidase/génétique , NADPH oxidase/métabolisme , Acide palmitique/pharmacologie , Animaux , Lignée cellulaire , Clones cellulaires , Amorces ADN , Femelle , Cellules à insuline/effets des médicaments et des substances chimiques , Ilots pancréatiques/effets des médicaments et des substances chimiques , Cinétique , Phagocytes/enzymologie , Rats , Rat Wistar , Espèces réactives de l'oxygène , TransfectionRÉSUMÉ
An improved synthesis of the precursor acetic acid-piperidine-4-yl ester by acetylation of 4-hydroxypiperidine hydrochloride in anhydrous chloroform was developed. A procedure for fast evaluation and characterization of products originated by acetylation of the 4-piperidinol using LC-APCI/MS with an acetonitrile-water gradient method on a Merck Purosphere RP-18 column was also developed. The highly purified precursor allowed the production of [11C]MP4A for PET studies of acetylcholine neurotransmission system. The tracer was produced with >98% radiochemical purity, with yields ranging 20-60% (decay-corrected) from EOB.
Sujet(s)
Acétates/synthèse chimique , Hydrocarbures iodés/composition chimique , Pipéridines/synthèse chimique , Radiopharmaceutiques/synthèse chimique , Acétates/composition chimique , Acétylation , Acetylcholinesterase/analyse , Chromatographie en phase liquide à haute performance , Chromatographie gazeuse-spectrométrie de masse , Humains , Marquage isotopique/méthodes , Spectroscopie par résonance magnétique , Pipéridines/composition chimique , Tomographie par émission de positons/méthodes , Radiopharmaceutiques/composition chimiqueRÉSUMÉ
OBJECTIVE: The hypothesis that changes in fatty acId composition of pancreatic islets occur during incubation was investigated. METHODS: The content and composition of fatty acIds (FA) from rat pancreatic islets and culture medium after incubation for 1 and 3 hours in the absence or in the presence of 5.6, 8.3, or 16.7 mM glucose were determined by HPLC analysis. RESULTS: The FA content of pancreatic islets was reduced after 1 hour incubation in the absence of glucose. However, the total FA content was restored by incubating in the presence of 5.6 mM glucose and exceeded by incubating in the presence of 8.3 mM or 16.7 mM glucose. Saturated FA contributed a substantially greater proportion of the total FA increase in comparison to unsaturated FA, being palmitic and stearic acIds the most important. The total lipId content of pancreatic islets was not increased if the period of incubation in the presence of glucose was extended to 3 hours. A substantial amount of FA was found in the medium after 1 hour incubation in the absence of glucose: 141 ng per 80 islets for saturated and 75 ng per 80 islets for unsaturated. The release of FA from islets is increased in the presence of glucose. CONCLUSION: The release of FA from islets is a novel finding and may be related to modulation of B-cell function.
Sujet(s)
Acide gras libre/métabolisme , Acides gras insaturés/métabolisme , Ilots pancréatiques/métabolisme , Animaux , Chromatographie en phase liquide à haute performance , Acide gras libre/isolement et purification , Acides gras insaturés/isolement et purification , Glucose/pharmacologie , Techniques in vitro , Ilots pancréatiques/effets des médicaments et des substances chimiques , Cinétique , Rats , Rat WistarRÉSUMÉ
OBJECTIVE: The relationship between Osteoarthritis (OA) and Osteoporosis (OP) is not well defined due to lacking in longitudinal data, mainly regarding correlations between biochemical factors and OA incidence. Aim of this paper was to investigate the predictive value for OA incidence of bone mass variations and of selected biochemical markers in healthy women participating in a population-based longitudinal study carried out in Naples (Italy). SUBJECTS AND METHODS: High completion rate (85.2%) and statistically adequate sample size were obtained: 139 women (45 to 79 years of age) were examined and follow up visit was performed after two years (24+/-2 months), following the same protocol. Patients underwent medical examination, questionnaire, anthropometric measurements, blood sampling and urine collection. Bone mineral density (BMD) measurement was performed by dual energy X-ray absorptiometry (DEXA) at the lumbar spine (L1-L4) and femoral neck. Radiographs of dorsal and lumbar spine in lateral view were performed at basal and at 24 months visits; a team of three experts scored radiographs using Kellgren and Lawrence grading. RESULTS: The score was calculated for two individual radiographic features (narrowing of the joint space, presence of osteophytes) and as a global score. Results show a relevant percentage, 23% up, of subjects presenting both OA and OP. In the cross-sectional study the presence of osteophytosis correlates with anthropometric variables and PTH levels. In the longitudinal study results show a correlation between serum vitamin D and delta score for osteophytosis (beta=0.02 p<0.05). CONCLUSIONS: Data obtained outline the importance of further studies on the pathogenetic link between OA and bone metabolism.
Sujet(s)
Os et tissu osseux/métabolisme , Arthrose/étiologie , Absorptiométrie photonique , Sujet âgé , Densité osseuse , Études transversales , Femelle , Col du fémur , Études de suivi , Humains , Études longitudinales , Vertèbres lombales/imagerie diagnostique , Adulte d'âge moyen , Arthrose/métabolisme , Taille de l'échantillon , Enquêtes et questionnaires , Facteurs tempsRÉSUMÉ
Hyperlipidemia is frequently associated with insulin resistance states as found in type 2 diabetes and obesity. Effects of free fatty acids (FFA) on pancreatic beta-cells have long been recognized. Acute exposure of the pancreatic beta-cell to FFA results in an increase of insulin release, whereas a chronic exposure results in desensitization and suppression of secretion. We recently showed that palmitate augments insulin release in the presence of non-stimulatory concentrations of glucose. Reduction of plasma FFA levels in fasted rats or humans severely impairs glucose-induced insulin release. These results imply that physiological plasma levels of FFA are important for beta-cell function. Although, it has been accepted that fatty acid oxidation is necessary for its stimulation of insulin secretion, the possible mechanisms by which fatty acids (FA) affect insulin secretion are discussed in this review. Long-chain acyl-CoA (LC-CoA) controls several aspects of the beta-cell function including activation of certain types of protein kinase C (PKC), modulation of ion channels, protein acylation, ceramide- and/or nitric oxide (NO)-mediated apoptosis, and binding to nuclear transcriptional factors. The present review also describes the possible effects of FA on insulin signaling. We showed for the first time that acute exposure of islets to palmitate upregulates the intracellular insulin-signaling pathway in pancreatic islets. Another aspect considered in this review is the source of FA for pancreatic islets. In addition to be exported to the medium, lipids can be transferred from leukocytes (macrophages) to pancreatic islets in co-culture. This process consists an additional source of FA that may plays a significant role to regulate insulin secretion.
Sujet(s)
Glycémie/métabolisme , Acide gras libre/métabolisme , Insulinorésistance/physiologie , Insuline/métabolisme , Ilots pancréatiques/métabolisme , Acyl coenzyme A/métabolisme , Animaux , Métabolisme énergétique/physiologie , Humains , Sécrétion d'insuline , Ilots pancréatiques/cytologie , Transduction du signal/physiologieRÉSUMÉ
Movement disorders, including Parkinson's disease and parkinsonian syndromes, e.g. progressive supranuclear palsy, multiple system atrophy, and Lewy body dementia, may be difficult to differentiate among each other at an early stage, since they may share similar clinical features and response to dopaminergic drugs. As new tracers for imaging the dopamine transporters become available, the use of positron emission tomography (PET) for the differential diagnosis of movement disorders is gaining clinical relevance. Visual interpretation is generally used for PET image analysis. However, the use of some form of less subjective analysis is desirable in order to detect subtle changes that may be difficult to identify by visual interpretation and to achieve an operator independent analysis. To this end this study was aimed at assessing the feasibility of using statistical parametric mapping (SPM) for the clinical evaluation of single PET scans performed with 2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane ( C-beta-CIT-FE). Eleven healthy volunteers and five patients with movement disorders (Parkinson's disease, essential tremor, PSP and Lewy body dementia) were included in this study. Each subject underwent a PET study after i.v. injection of C-beta-CIT-FE. The PET images of C-beta-CIT-FE distribution acquired between 60 and 90 min were spatially fitted into the Talairach and Tournoux space. A template of normal C-beta-CIT-FE distribution was derived from studies in the 11 normal control subjects. Different patterns of reduction of the uptake of the tracer were detected in the basal ganglia of the five patients, in relation to each pathological condition. The patterns of distribution were all consistent with the severity and type of disease. The results of this study demonstrate the feasibility of differentiating among different states of dopaminergic impairment, due to Parkinson's disease and parkinsonian syndromes, by using PET scans with C-beta-CIT-FE and by using the SPM procedure for analysis of the data.
Sujet(s)
Amélioration d'image/méthodes , Interprétation d'images assistée par ordinateur/méthodes , Troubles de la motricité/imagerie diagnostique , Nortropanes , Technique de soustraction , Tomoscintigraphie/méthodes , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Études de cohortes , Études de faisabilité , Femelle , Humains , Mâle , Adulte d'âge moyen , Modèles biologiques , Modèles statistiques , Valeur prédictive des tests , Radiopharmaceutiques , Normes de référence , Tomoscintigraphie/normesRÉSUMÉ
Amantadine, is a non competitive NMDA receptors antagonist that has been proved beneficial in Parkinson's disease. However its mechanism of action at therapeutic doses is still under discussion. Aim of this study was to evaluate the effect of repeated administration of amantadine on striatal dopaminergic system by measuring [(11)C]raclopride binding to striatal D(2) dopamine receptors, in patients with moderate idiopathic Parkinson's disease. Eight patients completed the study undergoing a PET scan, before and after 10-14 days treatment with Amantadine (200 mg/day). Patients were on treatment with L-DOPA, which was suspended 1 night before each PET scans, and free from dopaminergic agonists, anticholinergic and antidepressants. Amantadine treatment significantly increased [(11)C-]Raclopride binding (caudate: 10% p = 0.04; putamen 11% p = 0.01). A slight reduction (-7.3%, p = 0.062) of UPDRS total scores was also observed. The increased availability of striatal D(2) receptors, is likely to be caused by drug induced modification of receptors expression. This hypothesis is consistent with previous experiments, indicating an increase in striatal D(2) receptors in rats treated with amantadine or other non competitive NMDA antagonists and suggests that the neo-synthesis of D(2) receptors may represent a reinforcing mechanism of drug efficacy.
Sujet(s)
Amantadine/pharmacologie , Antiparkinsoniens/pharmacologie , Chimie du cerveau/effets des médicaments et des substances chimiques , Maladie de Parkinson/imagerie diagnostique , Maladie de Parkinson/métabolisme , Sujet âgé , Noyau caudé/imagerie diagnostique , Noyau caudé/métabolisme , Antagonistes de la dopamine , Femelle , Humains , Traitement d'image par ordinateur , Mâle , Adulte d'âge moyen , Néostriatum/effets des médicaments et des substances chimiques , Néostriatum/métabolisme , Putamen/imagerie diagnostique , Putamen/métabolisme , Raclopride , Radiopharmaceutiques , TomoscintigraphieRÉSUMÉ
The effect of 0.1 mM palmitate on insulin secretion by 1 hr incubated pancreatic islets was examined in the presence of different glucose concentrations (5.6 and 16.7 mM). The oxidation of both glucose and palmitate and the incorporation of [U-14C]-palmitate into lipid fractions and phospholipid species were determined. In the presence of 5.6 mM glucose, palmitate reduced insulin release by 80%. In contrast, in the presence of 16.7 mM glucose, palmitate raised the amount of insulin released by 49%. Palmitate (0.1 mM) caused a significant reduction (52%) of [U-14C]-glucose decarboxylation at 5.6 mM but it did not have any effect at 16.7 mM glucose. The decarboxylation of [U-14C]-palmitate was markedly lower (94%) in the presence of 16.7 mM, as compared to 5.6 mM glucose. [U-14C]-Palmitate was significantly incorporated into total lipid fractions in the presence of both glucose concentrations. The increase in glucose concentration from 5.6 to 16.7 mM raised by 138% the incorporation of [U-14C]-palmitate into phospholipids: phosphatidylcholine (PC), phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidic acid (PA) and phosphatidylinositol (PI). PC and PA at 0.1 mM raised by three and four-fold, respectively, insulin release by incubated pancreatic islets. We postulated that palmitate (at 0.1 mM) promotes a deviation of glycerol-phosphate to lipid synthesis, decreasing glucose oxidation (at 5.6 mM) and possibly ATP/ADP ratio in the cytosol, leading to a reduction in insulin secretion. At 16.7 mM glucose concentration, the high glycolytic flux is now enough to provide glycerol-phosphate for lipid synthesis and carbons for the Krebs cycle. So, under this condition, ATP production might be not reduced. The increase in the production of PA and PC may explain the increase in insulin secretion observed at 16.7 mM glucose.